Clinical Trials
2 trialsNCT00667017 2018-12-14
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT00430053 2012-03-15
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Completed